Concepedia

C. Zielinski

CZ

15

Publications

985

Citations

14

H-Index

1997

Active since

Affiliations

Vienna General Hospital(Current)

Ludwig Boltzmann Institute for Digital Health and Prevention

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA

Medical University of Vienna

University of Vienna

C. Zielinski is an author at Vienna General Hospital specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1997–2012

15

Publications

15

Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment

Wolfgang J. Köstler, Michael Hejna, C. Wenzel et al. · CA A Cancer Journal for Clinicians · 2001 · 364 citations · Full text

, , +15

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

Ursula Vogl, Harald Zehetgruber, Martin Dominkus et al. · British Journal of Cancer · 2006 · 100 citations · Full text

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

Barbara Kiesewetter, Marlene Troch, Werner Dolak et al. · Haematologica · 2012 · 84 citations · Full text

Capecitabine vs. capecitabine + trastuzumab in patients with HER2-positive metastatic breast cancer progressing during trastuzumab treatment: The TBP phase III study (GBG 26/BIG 3–05)

Gϋnter von Minckwitz, C. Zielinski, E. Maarteense et al. · Journal of Clinical Oncology · 2008 · 80 citations

, , +12

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

G Brufman, E Colajori, N. Ghilezan et al. · Annals of Oncology · 1997 · 79 citations · Full text

, , +8

Rows per page

1–5 of 15